- Home
- QUIK vs PLRX Comparison
QUIK vs PLRX Comparison
Compare QUIK & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QUIK | PLRX |
|---|---|---|
| Founded | 1988 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.5M | 79.9M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | QUIK | PLRX |
|---|---|---|
| Price | $9.21 | $1.39 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 9 |
| Target Price | ★ $11.00 | $3.75 |
| AVG Volume (30 Days) | 182.5K | ★ 621.1K |
| Earning Date | 06-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,112,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.38 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.26 | $1.09 |
| 52 Week High | $9.59 | $1.95 |
Technical Indicators
Market Signals| Indicator | QUIK | PLRX |
|---|---|---|
| Relative Strength Index (RSI) | 67.78 | 65.31 |
| Support Level | $5.96 | $1.12 |
| Resistance Level | N/A | $1.43 |
| Average True Range (ATR) | 0.59 | 0.06 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 79.25 | 94.59 |
Price Performance
Historical ComparisonAbout QUIK QuickLogic Corporation
QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.